Psifas conducts studies on targeted populations initiated in collaboration with leading investigators, to deepen the understanding of the genetic underpinning of selected diseases and to generate real world evidence that supports the development and optimization of new and existing treatment strategies.
Psifas conducts studies on targeted populations initiated in collaboration with leading investigators, to deepen the understanding of the genetic underpinning of selected diseases and to generate real world evidence that supports the development and optimization of new and existing treatment strategies.

Contracting
hospitals

IRB
approval

Study
Monitoring

Patients’
recruitment

CRF & data
acquisition
Psifas offers a streamlined, end-to-end solution for clinical studies through its “one-stop-shop” approach, managing the full operational lifecycle of research projects. From initiating contracts with participating hospitals to handling IRB preparation and approvals, Psifas ensures regulatory and administrative efficiency. The platform also oversees patient recruitment, study monitoring, and Case Report Form (CRF) completion, enabling investigators and sponsors to focus on scientific outcomes while benefiting from a coordinated and fully integrated research infrastructure.
Psifas offers a streamlined, end-to-end solution for clinical studies through its “one-stop-shop” approach, managing the full operational lifecycle of research projects. From initiating contracts with participating hospitals to handling IRB preparation and approvals, Psifas ensures regulatory and administrative efficiency. The platform also oversees patient recruitment, study monitoring, and Case Report Form (CRF) completion, enabling investigators and sponsors to focus on scientific outcomes while benefiting from a coordinated and fully integrated research infrastructure.
Investigator-Initiated Studies on targeted populations with Rare and Complex Conditions
Studies providing complementary parametric disease-specific information on top of HMO/Hospital and Genomic data.
Current studies at Psifas cover rare and complex medical conditions. All studies are IRB-approved, executed in collaboration with hospitals, and follow standardized protocols for data acquisition and biological sample collection. These studies are open for additional collaborators.
- Exposures and lifestyle
- Self and physicians’ assessments
- Encoded clinical information
- Patient Treatment Summary
- Optional additional complementary data and de-novo biological samples
- Graves’ without or with ophthalmopathy
- Pulmonary fibrosis
- Hidradenitis suppurativa
- Myelodysplastic syndrome (MDS)
- Tumors and polyps in the gastrointestinal tract
- Young oncology
- High Myopia
- Uveitis
- Pseudotumor Cerebri
- Myasthenia gravis
- Autoimmune adverse events check point inhibitors
- Keratoconus
- Severe schizophrenia